Addictive properties of drug abuse may hold key to an HIV cure

A Florida State University researcher is on a mission to explore the gene-controlling effects of addictive drugs in pursuit of new HIV treatments.

Working under the support of a $1.8 million grant from the National Institutes of Health (NIH), Florida State biologist Jonathan Dennis is studying a unique ability shared between a promising class of known as histone deacetylase inhibitors (HDIs) and such as cocaine.

"Current HIV treatments do just that—they treat the disease by preventing the spread of HIV in the body, rather than eliminating the disease entirely," Dennis said. "I want to find out how to root out those dormant HIV cells that are evading the treatment, and I believe the gene-controlling functions shared by HDIs and psychostimulant drugs hold the key to helping us do that."

HDI and such as cocaine share the ability to control through changes in the chromatin structure within DNA. In the case of HDI treatment, the chromatin changes are used to wake up dormant cells that are hiding in the body.

Dennis believes that addictive drugs do the same thing. Dennis' work will focus on identifying and understanding the overlapping gene changes that occur between these two types of substances, ultimately providing other researchers with the foundational information they need to turn HDI treatments into HIV cures.

To learn more about the scope and purpose of Dennis' NIH grant, visit the grant website. To learn more about Dennis, visit his Department of Biological Science website.

add to favorites email to friend print save as pdf

Related Stories

New book on HIV from Cold Spring Harbor Laboratory Press

Dec 15, 2011

The worldwide AIDS epidemic makes research on HIV, the disease processes it induces, and potential HIV therapies among the most critical in biomedical science. Furthermore, the basic biology of HIV infections ...

New discoveries make it harder for HIV to hide from drugs

Dec 15, 2010

The virus that causes AIDS is chameleon-like in its replication. As HIV copies itself in humans, it constantly mutates into forms that can evade even the best cocktail of current therapies. Understanding exactly how HIV cells ...

Ridding the human body of HIV

Dec 02, 2010

A new Northwestern Medicine study will undertake a bold new protocol to completely eradicate latent HIV cells that current drugs don't affect. Participants, with diagnosed HIV, in the experimental group will be given an investigational ...

Recommended for you

Intimacy a strong motivator for PrEP HIV prevention

Aug 19, 2014

Men in steady same-sex relationships where both partners are HIV negative will often forgo condoms out of a desire to preserve intimacy, even if they also have sex outside the relationship. But the risk of ...

UNL sociologist studies HIV spread in rural Puerto Rico

Aug 14, 2014

Puerto Rico has one of the highest HIV rates in the United States, primarily from drug users sharing needles. To help prevent HIV infections, a University of Nebraska-Lincoln sociologist is using his expertise ...

User comments